Global Cold Sore Treatment Market
Global Cold Sore Treatment Market

Cold Sore Treatment Comprehensive Study by Type (Non-Pharmacological Treatment, Pharmacological Treatment), Application (Hospitals, Homecare, Specialty Clinics, Others), Drug Type (Antiviral Ointments, Oral Antiviral Agents), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Virus Type (Herpes Simplex Type 1 Virus, Herpes Simplex Type 2 Virus) Players and Region - Global Market Outlook to 2025

Cold Sore Treatment Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Sep 2020 Edition 217 Pages 214 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Cold Sore Treatment Market Scope
A cold sore, also called herpes labialis, is a viral infection caused by the herpes simplex virus. It is characterized by red, fluid-filled blisters or ulcers that appear on the lips and around the mouth. These blisters often appear as spots when they break a crust that forms over the resulting wound. According to statistics released by WebMD LLC, an estimated 40% of the US adult population get recurrent cold sores. The high demand for novel treatment methods and enormous investments in research and development are drivers for market growth. In 2019, the Abreva brand, one of the leading cold sore brands in the United States, accounted for approximately 71.1 percent of total US dollar sales.

The market study is being classified by Type (Non-Pharmacological Treatment and Pharmacological Treatment), by Application (Hospitals, Homecare, Specialty Clinics and Others) and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Cold Sore Treatment market throughout the predicted period.

Squarex (United States), Merix Pharmaceutical Corp (United States), AiCuris (Germany), GlaxoSmithKline plc (United Kingdom), Medivir AB (Sweden), Renaissance Pharma, Inc. (United States), Deerfield (United States), Otsuka Holdings Co. Ltd. (Japan), Mylan N.V. (United States), Teva Pharmaceutical Industries Ltd. (Israel), Cipla Inc. (India), Alembic Pharmaceuticals Limited (India), Zydus Cadila (India), Amneal Pharmaceuticals LLC (United States), Sun Pharmaceutical Industries Ltd. (India) and Hetero Drugs (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Novartis AG (Switzerland) and Tolmar Pharmaceuticals, Inc. (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Cold Sore Treatment market by Type, Application and Region.

On the basis of geography, the market of Cold Sore Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In August 2019, Merix Pharmaceutical Corp launched RELEEV, which contains VIRACEA, a proprietary herbal extract formulation made from Echinacea extract and antiseptic benzalkonium chloride for the treatment of cold sores. This drug claims to relieve cold sore pain in just 3 to 10 minutes and relieve other symptoms in 24 hours. The introduction of this drug offers a novel topical treatment and important advances that will allow a complete cure for this condition.


Market Trend
  • Huge Financial Support to the Researchers for Developing Novel Intervention
  • High Demand for Disease-Specific Novel Treatment
  • Increase in Modes of Transmission of the Infectious Disease
  • Lack of Cleanliness in Developing Regions

Market Drivers
  • Growing Prevalence of Cold Sore Worldwide
  • A Rise in Prevalence of HSV Infection
  • Increase in Rate of New Infections
  • Continuous Mutations in the Microorganisms Leading To New Strains

Opportunities
  • A Rapid Pace in the Near Future Due To Rising Adoption of Online Purchases in Developed Countries
  • Advancement in Treatment and Incorporation of Novel Formulation Can Improve the Ease the Pain of Cold Sores

Restraints
  • Patent Expiry of Branded Drugs and Introduction of Generics

Challenges
  • Low Healthcare Budget in Some Developing Countries


Key Target Audience
Providers of Cold Sore BodiesTreatment, End-Users, Potential Investors, Market Research Firms, Regulatory and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Non-Pharmacological Treatment
  • Pharmacological Treatment
By Application
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
By Drug Type
  • Antiviral Ointments
  • Oral Antiviral Agents

By Route of Administration
  • Oral
  • Topical

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Virus Type
  • Herpes Simplex Type 1 Virus
  • Herpes Simplex Type 2 Virus

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Cold Sore Worldwide
      • 3.2.2. A Rise in Prevalence of HSV Infection
      • 3.2.3. Increase in Rate of New Infections
      • 3.2.4. Continuous Mutations in the Microorganisms Leading To New Strains
    • 3.3. Market Challenges
      • 3.3.1. Low Healthcare Budget in Some Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Huge Financial Support to the Researchers for Developing Novel Intervention
      • 3.4.2. High Demand for Disease-Specific Novel Treatment
      • 3.4.3. Increase in Modes of Transmission of the Infectious Disease
      • 3.4.4. Lack of Cleanliness in Developing Regions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cold Sore Treatment, by Type, Application, Drug Type, Route of Administration, Distribution Channel, Virus Type and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Cold Sore Treatment (Value)
      • 5.2.1. Global Cold Sore Treatment by: Type (Value)
        • 5.2.1.1. Non-Pharmacological Treatment
        • 5.2.1.2. Pharmacological Treatment
      • 5.2.2. Global Cold Sore Treatment by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Homecare
        • 5.2.2.3. Specialty Clinics
        • 5.2.2.4. Others
      • 5.2.3. Global Cold Sore Treatment by: Drug Type (Value)
        • 5.2.3.1. Antiviral Ointments
        • 5.2.3.2. Oral Antiviral Agents
      • 5.2.4. Global Cold Sore Treatment by: Route of Administration (Value)
        • 5.2.4.1. Oral
        • 5.2.4.2. Topical
      • 5.2.5. Global Cold Sore Treatment by: Distribution Channel (Value)
        • 5.2.5.1. Hospital Pharmacies
        • 5.2.5.2. Retail Pharmacies
        • 5.2.5.3. Online Pharmacies
      • 5.2.6. Global Cold Sore Treatment by: Virus Type (Value)
        • 5.2.6.1. Herpes Simplex Type 1 Virus
        • 5.2.6.2. Herpes Simplex Type 2 Virus
      • 5.2.7. Global Cold Sore Treatment Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Cold Sore Treatment (Volume)
      • 5.3.1. Global Cold Sore Treatment by: Type (Volume)
        • 5.3.1.1. Non-Pharmacological Treatment
        • 5.3.1.2. Pharmacological Treatment
      • 5.3.2. Global Cold Sore Treatment by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Homecare
        • 5.3.2.3. Specialty Clinics
        • 5.3.2.4. Others
      • 5.3.3. Global Cold Sore Treatment by: Drug Type (Volume)
        • 5.3.3.1. Antiviral Ointments
        • 5.3.3.2. Oral Antiviral Agents
      • 5.3.4. Global Cold Sore Treatment by: Route of Administration (Volume)
        • 5.3.4.1. Oral
        • 5.3.4.2. Topical
      • 5.3.5. Global Cold Sore Treatment by: Distribution Channel (Volume)
        • 5.3.5.1. Hospital Pharmacies
        • 5.3.5.2. Retail Pharmacies
        • 5.3.5.3. Online Pharmacies
      • 5.3.6. Global Cold Sore Treatment by: Virus Type (Volume)
        • 5.3.6.1. Herpes Simplex Type 1 Virus
        • 5.3.6.2. Herpes Simplex Type 2 Virus
      • 5.3.7. Global Cold Sore Treatment Region
        • 5.3.7.1. South America
          • 5.3.7.1.1. Brazil
          • 5.3.7.1.2. Argentina
          • 5.3.7.1.3. Rest of South America
        • 5.3.7.2. Asia Pacific
          • 5.3.7.2.1. China
          • 5.3.7.2.2. Japan
          • 5.3.7.2.3. India
          • 5.3.7.2.4. South Korea
          • 5.3.7.2.5. Taiwan
          • 5.3.7.2.6. Australia
          • 5.3.7.2.7. Rest of Asia-Pacific
        • 5.3.7.3. Europe
          • 5.3.7.3.1. Germany
          • 5.3.7.3.2. France
          • 5.3.7.3.3. Italy
          • 5.3.7.3.4. United Kingdom
          • 5.3.7.3.5. Netherlands
          • 5.3.7.3.6. Rest of Europe
        • 5.3.7.4. MEA
          • 5.3.7.4.1. Middle East
          • 5.3.7.4.2. Africa
        • 5.3.7.5. North America
          • 5.3.7.5.1. United States
          • 5.3.7.5.2. Canada
          • 5.3.7.5.3. Mexico
    • 5.4. Global Cold Sore Treatment (Price)
      • 5.4.1. Global Cold Sore Treatment by: Type (Price)
  • 6. Cold Sore Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Squarex (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merix Pharmaceutical Corp (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AiCuris (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GlaxoSmithKline plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medivir AB (Sweden)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Renaissance Pharma, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Deerfield (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Otsuka Holdings Co. Ltd. (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mylan N.V. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cipla Inc. (India)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Alembic Pharmaceuticals Limited (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Zydus Cadila (India)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Amneal Pharmaceuticals LLC (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Sun Pharmaceutical Industries Ltd. (India)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Hetero Drugs (India)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Cold Sore Treatment Sale, by Type, Application, Drug Type, Route of Administration, Distribution Channel, Virus Type and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Cold Sore Treatment (Value)
      • 7.2.1. Global Cold Sore Treatment by: Type (Value)
        • 7.2.1.1. Non-Pharmacological Treatment
        • 7.2.1.2. Pharmacological Treatment
      • 7.2.2. Global Cold Sore Treatment by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Homecare
        • 7.2.2.3. Specialty Clinics
        • 7.2.2.4. Others
      • 7.2.3. Global Cold Sore Treatment by: Drug Type (Value)
        • 7.2.3.1. Antiviral Ointments
        • 7.2.3.2. Oral Antiviral Agents
      • 7.2.4. Global Cold Sore Treatment by: Route of Administration (Value)
        • 7.2.4.1. Oral
        • 7.2.4.2. Topical
      • 7.2.5. Global Cold Sore Treatment by: Distribution Channel (Value)
        • 7.2.5.1. Hospital Pharmacies
        • 7.2.5.2. Retail Pharmacies
        • 7.2.5.3. Online Pharmacies
      • 7.2.6. Global Cold Sore Treatment by: Virus Type (Value)
        • 7.2.6.1. Herpes Simplex Type 1 Virus
        • 7.2.6.2. Herpes Simplex Type 2 Virus
      • 7.2.7. Global Cold Sore Treatment Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Cold Sore Treatment (Volume)
      • 7.3.1. Global Cold Sore Treatment by: Type (Volume)
        • 7.3.1.1. Non-Pharmacological Treatment
        • 7.3.1.2. Pharmacological Treatment
      • 7.3.2. Global Cold Sore Treatment by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Homecare
        • 7.3.2.3. Specialty Clinics
        • 7.3.2.4. Others
      • 7.3.3. Global Cold Sore Treatment by: Drug Type (Volume)
        • 7.3.3.1. Antiviral Ointments
        • 7.3.3.2. Oral Antiviral Agents
      • 7.3.4. Global Cold Sore Treatment by: Route of Administration (Volume)
        • 7.3.4.1. Oral
        • 7.3.4.2. Topical
      • 7.3.5. Global Cold Sore Treatment by: Distribution Channel (Volume)
        • 7.3.5.1. Hospital Pharmacies
        • 7.3.5.2. Retail Pharmacies
        • 7.3.5.3. Online Pharmacies
      • 7.3.6. Global Cold Sore Treatment by: Virus Type (Volume)
        • 7.3.6.1. Herpes Simplex Type 1 Virus
        • 7.3.6.2. Herpes Simplex Type 2 Virus
      • 7.3.7. Global Cold Sore Treatment Region
        • 7.3.7.1. South America
          • 7.3.7.1.1. Brazil
          • 7.3.7.1.2. Argentina
          • 7.3.7.1.3. Rest of South America
        • 7.3.7.2. Asia Pacific
          • 7.3.7.2.1. China
          • 7.3.7.2.2. Japan
          • 7.3.7.2.3. India
          • 7.3.7.2.4. South Korea
          • 7.3.7.2.5. Taiwan
          • 7.3.7.2.6. Australia
          • 7.3.7.2.7. Rest of Asia-Pacific
        • 7.3.7.3. Europe
          • 7.3.7.3.1. Germany
          • 7.3.7.3.2. France
          • 7.3.7.3.3. Italy
          • 7.3.7.3.4. United Kingdom
          • 7.3.7.3.5. Netherlands
          • 7.3.7.3.6. Rest of Europe
        • 7.3.7.4. MEA
          • 7.3.7.4.1. Middle East
          • 7.3.7.4.2. Africa
        • 7.3.7.5. North America
          • 7.3.7.5.1. United States
          • 7.3.7.5.2. Canada
          • 7.3.7.5.3. Mexico
    • 7.4. Global Cold Sore Treatment (Price)
      • 7.4.1. Global Cold Sore Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cold Sore Treatment: by Type(USD Million)
  • Table 2. Cold Sore Treatment Non-Pharmacological Treatment , by Region USD Million (2014-2019)
  • Table 3. Cold Sore Treatment Pharmacological Treatment , by Region USD Million (2014-2019)
  • Table 4. Cold Sore Treatment: by Application(USD Million)
  • Table 5. Cold Sore Treatment Hospitals , by Region USD Million (2014-2019)
  • Table 6. Cold Sore Treatment Homecare , by Region USD Million (2014-2019)
  • Table 7. Cold Sore Treatment Specialty Clinics , by Region USD Million (2014-2019)
  • Table 8. Cold Sore Treatment Others , by Region USD Million (2014-2019)
  • Table 9. Cold Sore Treatment: by Drug Type(USD Million)
  • Table 10. Cold Sore Treatment Antiviral Ointments , by Region USD Million (2014-2019)
  • Table 11. Cold Sore Treatment Oral Antiviral Agents , by Region USD Million (2014-2019)
  • Table 12. Cold Sore Treatment: by Route of Administration(USD Million)
  • Table 13. Cold Sore Treatment Oral , by Region USD Million (2014-2019)
  • Table 14. Cold Sore Treatment Topical , by Region USD Million (2014-2019)
  • Table 15. Cold Sore Treatment: by Distribution Channel(USD Million)
  • Table 16. Cold Sore Treatment Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 17. Cold Sore Treatment Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 18. Cold Sore Treatment Online Pharmacies , by Region USD Million (2014-2019)
  • Table 19. Cold Sore Treatment: by Virus Type(USD Million)
  • Table 20. Cold Sore Treatment Herpes Simplex Type 1 Virus , by Region USD Million (2014-2019)
  • Table 21. Cold Sore Treatment Herpes Simplex Type 2 Virus , by Region USD Million (2014-2019)
  • Table 22. South America Cold Sore Treatment, by Country USD Million (2014-2019)
  • Table 23. South America Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 24. South America Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 25. South America Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 26. South America Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 27. South America Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 28. South America Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 29. Brazil Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 30. Brazil Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 31. Brazil Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 32. Brazil Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 33. Brazil Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 34. Brazil Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 35. Argentina Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 36. Argentina Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 37. Argentina Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 38. Argentina Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 39. Argentina Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 40. Argentina Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 41. Rest of South America Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 42. Rest of South America Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 43. Rest of South America Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 44. Rest of South America Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 45. Rest of South America Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 46. Rest of South America Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 47. Asia Pacific Cold Sore Treatment, by Country USD Million (2014-2019)
  • Table 48. Asia Pacific Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 49. Asia Pacific Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 50. Asia Pacific Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 51. Asia Pacific Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 52. Asia Pacific Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 53. Asia Pacific Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 54. China Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 55. China Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 56. China Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 57. China Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 58. China Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 59. China Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 60. Japan Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 61. Japan Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 62. Japan Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 63. Japan Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 64. Japan Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 65. Japan Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 66. India Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 67. India Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 68. India Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 69. India Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 70. India Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 71. India Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 72. South Korea Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 73. South Korea Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 74. South Korea Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 75. South Korea Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 76. South Korea Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 77. South Korea Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 78. Taiwan Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 79. Taiwan Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 80. Taiwan Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 81. Taiwan Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 82. Taiwan Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 83. Taiwan Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 84. Australia Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 85. Australia Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 86. Australia Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 87. Australia Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 88. Australia Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 89. Australia Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 90. Rest of Asia-Pacific Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 91. Rest of Asia-Pacific Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 92. Rest of Asia-Pacific Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 93. Rest of Asia-Pacific Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 94. Rest of Asia-Pacific Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 95. Rest of Asia-Pacific Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 96. Europe Cold Sore Treatment, by Country USD Million (2014-2019)
  • Table 97. Europe Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 98. Europe Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 99. Europe Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 100. Europe Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 101. Europe Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 102. Europe Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 103. Germany Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 104. Germany Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 105. Germany Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 106. Germany Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 107. Germany Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 108. Germany Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 109. France Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 110. France Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 111. France Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 112. France Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 113. France Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 114. France Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 115. Italy Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 116. Italy Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 117. Italy Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 118. Italy Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 119. Italy Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 120. Italy Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 121. United Kingdom Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 122. United Kingdom Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 123. United Kingdom Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 124. United Kingdom Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 125. United Kingdom Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 126. United Kingdom Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 127. Netherlands Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 128. Netherlands Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 129. Netherlands Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 130. Netherlands Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 131. Netherlands Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 132. Netherlands Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 133. Rest of Europe Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 134. Rest of Europe Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 135. Rest of Europe Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 136. Rest of Europe Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 137. Rest of Europe Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 138. Rest of Europe Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 139. MEA Cold Sore Treatment, by Country USD Million (2014-2019)
  • Table 140. MEA Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 141. MEA Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 142. MEA Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 143. MEA Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 144. MEA Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 145. MEA Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 146. Middle East Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 147. Middle East Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 148. Middle East Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 149. Middle East Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 150. Middle East Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 151. Middle East Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 152. Africa Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 153. Africa Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 154. Africa Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 155. Africa Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 156. Africa Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 157. Africa Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 158. North America Cold Sore Treatment, by Country USD Million (2014-2019)
  • Table 159. North America Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 160. North America Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 161. North America Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 162. North America Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 163. North America Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 164. North America Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 165. United States Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 166. United States Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 167. United States Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 168. United States Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 169. United States Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 170. United States Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 171. Canada Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 172. Canada Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 173. Canada Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 174. Canada Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 175. Canada Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 176. Canada Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 177. Mexico Cold Sore Treatment, by Type USD Million (2014-2019)
  • Table 178. Mexico Cold Sore Treatment, by Application USD Million (2014-2019)
  • Table 179. Mexico Cold Sore Treatment, by Drug Type USD Million (2014-2019)
  • Table 180. Mexico Cold Sore Treatment, by Route of Administration USD Million (2014-2019)
  • Table 181. Mexico Cold Sore Treatment, by Distribution Channel USD Million (2014-2019)
  • Table 182. Mexico Cold Sore Treatment, by Virus Type USD Million (2014-2019)
  • Table 183. Cold Sore Treatment Sales: by Type(K Tons)
  • Table 184. Cold Sore Treatment Sales Non-Pharmacological Treatment , by Region K Tons (2014-2019)
  • Table 185. Cold Sore Treatment Sales Pharmacological Treatment , by Region K Tons (2014-2019)
  • Table 186. Cold Sore Treatment Sales: by Application(K Tons)
  • Table 187. Cold Sore Treatment Sales Hospitals , by Region K Tons (2014-2019)
  • Table 188. Cold Sore Treatment Sales Homecare , by Region K Tons (2014-2019)
  • Table 189. Cold Sore Treatment Sales Specialty Clinics , by Region K Tons (2014-2019)
  • Table 190. Cold Sore Treatment Sales Others , by Region K Tons (2014-2019)
  • Table 191. Cold Sore Treatment Sales: by Drug Type(K Tons)
  • Table 192. Cold Sore Treatment Sales Antiviral Ointments , by Region K Tons (2014-2019)
  • Table 193. Cold Sore Treatment Sales Oral Antiviral Agents , by Region K Tons (2014-2019)
  • Table 194. Cold Sore Treatment Sales: by Route of Administration(K Tons)
  • Table 195. Cold Sore Treatment Sales Oral , by Region K Tons (2014-2019)
  • Table 196. Cold Sore Treatment Sales Topical , by Region K Tons (2014-2019)
  • Table 197. Cold Sore Treatment Sales: by Distribution Channel(K Tons)
  • Table 198. Cold Sore Treatment Sales Hospital Pharmacies , by Region K Tons (2014-2019)
  • Table 199. Cold Sore Treatment Sales Retail Pharmacies , by Region K Tons (2014-2019)
  • Table 200. Cold Sore Treatment Sales Online Pharmacies , by Region K Tons (2014-2019)
  • Table 201. Cold Sore Treatment Sales: by Virus Type(K Tons)
  • Table 202. Cold Sore Treatment Sales Herpes Simplex Type 1 Virus , by Region K Tons (2014-2019)
  • Table 203. Cold Sore Treatment Sales Herpes Simplex Type 2 Virus , by Region K Tons (2014-2019)
  • Table 204. South America Cold Sore Treatment Sales, by Country K Tons (2014-2019)
  • Table 205. South America Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 206. South America Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 207. South America Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 208. South America Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 209. South America Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 210. South America Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 211. Brazil Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 212. Brazil Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 213. Brazil Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 214. Brazil Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 215. Brazil Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 216. Brazil Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 217. Argentina Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 218. Argentina Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 219. Argentina Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 220. Argentina Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 221. Argentina Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 222. Argentina Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 223. Rest of South America Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 224. Rest of South America Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 225. Rest of South America Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 226. Rest of South America Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 227. Rest of South America Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 228. Rest of South America Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 229. Asia Pacific Cold Sore Treatment Sales, by Country K Tons (2014-2019)
  • Table 230. Asia Pacific Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 231. Asia Pacific Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 232. Asia Pacific Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 233. Asia Pacific Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 234. Asia Pacific Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 235. Asia Pacific Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 236. China Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 237. China Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 238. China Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 239. China Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 240. China Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 241. China Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 242. Japan Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 243. Japan Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 244. Japan Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 245. Japan Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 246. Japan Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 247. Japan Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 248. India Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 249. India Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 250. India Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 251. India Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 252. India Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 253. India Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 254. South Korea Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 255. South Korea Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 256. South Korea Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 257. South Korea Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 258. South Korea Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 259. South Korea Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 260. Taiwan Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 261. Taiwan Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 262. Taiwan Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 263. Taiwan Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 264. Taiwan Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 265. Taiwan Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 266. Australia Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 267. Australia Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 268. Australia Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 269. Australia Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 270. Australia Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 271. Australia Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 272. Rest of Asia-Pacific Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 273. Rest of Asia-Pacific Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 274. Rest of Asia-Pacific Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 275. Rest of Asia-Pacific Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 276. Rest of Asia-Pacific Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 277. Rest of Asia-Pacific Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 278. Europe Cold Sore Treatment Sales, by Country K Tons (2014-2019)
  • Table 279. Europe Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 280. Europe Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 281. Europe Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 282. Europe Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 283. Europe Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 284. Europe Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 285. Germany Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 286. Germany Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 287. Germany Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 288. Germany Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 289. Germany Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 290. Germany Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 291. France Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 292. France Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 293. France Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 294. France Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 295. France Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 296. France Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 297. Italy Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 298. Italy Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 299. Italy Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 300. Italy Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 301. Italy Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 302. Italy Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 303. United Kingdom Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 304. United Kingdom Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 305. United Kingdom Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 306. United Kingdom Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 307. United Kingdom Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 308. United Kingdom Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 309. Netherlands Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 310. Netherlands Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 311. Netherlands Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 312. Netherlands Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 313. Netherlands Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 314. Netherlands Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 315. Rest of Europe Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 316. Rest of Europe Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 317. Rest of Europe Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 318. Rest of Europe Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 319. Rest of Europe Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 320. Rest of Europe Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 321. MEA Cold Sore Treatment Sales, by Country K Tons (2014-2019)
  • Table 322. MEA Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 323. MEA Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 324. MEA Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 325. MEA Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 326. MEA Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 327. MEA Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 328. Middle East Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 329. Middle East Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 330. Middle East Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 331. Middle East Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 332. Middle East Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 333. Middle East Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 334. Africa Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 335. Africa Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 336. Africa Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 337. Africa Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 338. Africa Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 339. Africa Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 340. North America Cold Sore Treatment Sales, by Country K Tons (2014-2019)
  • Table 341. North America Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 342. North America Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 343. North America Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 344. North America Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 345. North America Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 346. North America Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 347. United States Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 348. United States Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 349. United States Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 350. United States Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 351. United States Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 352. United States Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 353. Canada Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 354. Canada Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 355. Canada Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 356. Canada Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 357. Canada Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 358. Canada Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 359. Mexico Cold Sore Treatment Sales, by Type K Tons (2014-2019)
  • Table 360. Mexico Cold Sore Treatment Sales, by Application K Tons (2014-2019)
  • Table 361. Mexico Cold Sore Treatment Sales, by Drug Type K Tons (2014-2019)
  • Table 362. Mexico Cold Sore Treatment Sales, by Route of Administration K Tons (2014-2019)
  • Table 363. Mexico Cold Sore Treatment Sales, by Distribution Channel K Tons (2014-2019)
  • Table 364. Mexico Cold Sore Treatment Sales, by Virus Type K Tons (2014-2019)
  • Table 365. Cold Sore Treatment: by Type(USD/Units)
  • Table 366. Company Basic Information, Sales Area and Its Competitors
  • Table 367. Company Basic Information, Sales Area and Its Competitors
  • Table 368. Company Basic Information, Sales Area and Its Competitors
  • Table 369. Company Basic Information, Sales Area and Its Competitors
  • Table 370. Company Basic Information, Sales Area and Its Competitors
  • Table 371. Company Basic Information, Sales Area and Its Competitors
  • Table 372. Company Basic Information, Sales Area and Its Competitors
  • Table 373. Company Basic Information, Sales Area and Its Competitors
  • Table 374. Company Basic Information, Sales Area and Its Competitors
  • Table 375. Company Basic Information, Sales Area and Its Competitors
  • Table 376. Company Basic Information, Sales Area and Its Competitors
  • Table 377. Company Basic Information, Sales Area and Its Competitors
  • Table 378. Company Basic Information, Sales Area and Its Competitors
  • Table 379. Company Basic Information, Sales Area and Its Competitors
  • Table 380. Company Basic Information, Sales Area and Its Competitors
  • Table 381. Company Basic Information, Sales Area and Its Competitors
  • Table 382. Cold Sore Treatment: by Type(USD Million)
  • Table 383. Cold Sore Treatment Non-Pharmacological Treatment , by Region USD Million (2020-2025)
  • Table 384. Cold Sore Treatment Pharmacological Treatment , by Region USD Million (2020-2025)
  • Table 385. Cold Sore Treatment: by Application(USD Million)
  • Table 386. Cold Sore Treatment Hospitals , by Region USD Million (2020-2025)
  • Table 387. Cold Sore Treatment Homecare , by Region USD Million (2020-2025)
  • Table 388. Cold Sore Treatment Specialty Clinics , by Region USD Million (2020-2025)
  • Table 389. Cold Sore Treatment Others , by Region USD Million (2020-2025)
  • Table 390. Cold Sore Treatment: by Drug Type(USD Million)
  • Table 391. Cold Sore Treatment Antiviral Ointments , by Region USD Million (2020-2025)
  • Table 392. Cold Sore Treatment Oral Antiviral Agents , by Region USD Million (2020-2025)
  • Table 393. Cold Sore Treatment: by Route of Administration(USD Million)
  • Table 394. Cold Sore Treatment Oral , by Region USD Million (2020-2025)
  • Table 395. Cold Sore Treatment Topical , by Region USD Million (2020-2025)
  • Table 396. Cold Sore Treatment: by Distribution Channel(USD Million)
  • Table 397. Cold Sore Treatment Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 398. Cold Sore Treatment Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 399. Cold Sore Treatment Online Pharmacies , by Region USD Million (2020-2025)
  • Table 400. Cold Sore Treatment: by Virus Type(USD Million)
  • Table 401. Cold Sore Treatment Herpes Simplex Type 1 Virus , by Region USD Million (2020-2025)
  • Table 402. Cold Sore Treatment Herpes Simplex Type 2 Virus , by Region USD Million (2020-2025)
  • Table 403. South America Cold Sore Treatment, by Country USD Million (2020-2025)
  • Table 404. South America Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 405. South America Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 406. South America Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 407. South America Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 408. South America Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 409. South America Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 410. Brazil Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 411. Brazil Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 412. Brazil Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 413. Brazil Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 414. Brazil Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 415. Brazil Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 416. Argentina Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 417. Argentina Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 418. Argentina Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 419. Argentina Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 420. Argentina Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 421. Argentina Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 422. Rest of South America Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 423. Rest of South America Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 424. Rest of South America Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 425. Rest of South America Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 426. Rest of South America Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 427. Rest of South America Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 428. Asia Pacific Cold Sore Treatment, by Country USD Million (2020-2025)
  • Table 429. Asia Pacific Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 430. Asia Pacific Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 431. Asia Pacific Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 432. Asia Pacific Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 433. Asia Pacific Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 434. Asia Pacific Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 435. China Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 436. China Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 437. China Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 438. China Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 439. China Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 440. China Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 441. Japan Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 442. Japan Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 443. Japan Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 444. Japan Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 445. Japan Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 446. Japan Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 447. India Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 448. India Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 449. India Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 450. India Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 451. India Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 452. India Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 453. South Korea Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 454. South Korea Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 455. South Korea Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 456. South Korea Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 457. South Korea Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 458. South Korea Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 459. Taiwan Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 460. Taiwan Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 461. Taiwan Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 462. Taiwan Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 463. Taiwan Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 464. Taiwan Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 465. Australia Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 466. Australia Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 467. Australia Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 468. Australia Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 469. Australia Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 470. Australia Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 471. Rest of Asia-Pacific Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 472. Rest of Asia-Pacific Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 473. Rest of Asia-Pacific Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 474. Rest of Asia-Pacific Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 475. Rest of Asia-Pacific Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 476. Rest of Asia-Pacific Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 477. Europe Cold Sore Treatment, by Country USD Million (2020-2025)
  • Table 478. Europe Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 479. Europe Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 480. Europe Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 481. Europe Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 482. Europe Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 483. Europe Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 484. Germany Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 485. Germany Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 486. Germany Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 487. Germany Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 488. Germany Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 489. Germany Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 490. France Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 491. France Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 492. France Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 493. France Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 494. France Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 495. France Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 496. Italy Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 497. Italy Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 498. Italy Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 499. Italy Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 500. Italy Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 501. Italy Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 502. United Kingdom Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 503. United Kingdom Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 504. United Kingdom Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 505. United Kingdom Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 506. United Kingdom Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 507. United Kingdom Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 508. Netherlands Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 509. Netherlands Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 510. Netherlands Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 511. Netherlands Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 512. Netherlands Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 513. Netherlands Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 514. Rest of Europe Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 515. Rest of Europe Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 516. Rest of Europe Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 517. Rest of Europe Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 518. Rest of Europe Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 519. Rest of Europe Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 520. MEA Cold Sore Treatment, by Country USD Million (2020-2025)
  • Table 521. MEA Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 522. MEA Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 523. MEA Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 524. MEA Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 525. MEA Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 526. MEA Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 527. Middle East Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 528. Middle East Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 529. Middle East Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 530. Middle East Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 531. Middle East Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 532. Middle East Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 533. Africa Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 534. Africa Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 535. Africa Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 536. Africa Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 537. Africa Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 538. Africa Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 539. North America Cold Sore Treatment, by Country USD Million (2020-2025)
  • Table 540. North America Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 541. North America Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 542. North America Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 543. North America Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 544. North America Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 545. North America Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 546. United States Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 547. United States Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 548. United States Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 549. United States Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 550. United States Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 551. United States Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 552. Canada Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 553. Canada Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 554. Canada Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 555. Canada Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 556. Canada Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 557. Canada Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 558. Mexico Cold Sore Treatment, by Type USD Million (2020-2025)
  • Table 559. Mexico Cold Sore Treatment, by Application USD Million (2020-2025)
  • Table 560. Mexico Cold Sore Treatment, by Drug Type USD Million (2020-2025)
  • Table 561. Mexico Cold Sore Treatment, by Route of Administration USD Million (2020-2025)
  • Table 562. Mexico Cold Sore Treatment, by Distribution Channel USD Million (2020-2025)
  • Table 563. Mexico Cold Sore Treatment, by Virus Type USD Million (2020-2025)
  • Table 564. Cold Sore Treatment Sales: by Type(K Tons)
  • Table 565. Cold Sore Treatment Sales Non-Pharmacological Treatment , by Region K Tons (2020-2025)
  • Table 566. Cold Sore Treatment Sales Pharmacological Treatment , by Region K Tons (2020-2025)
  • Table 567. Cold Sore Treatment Sales: by Application(K Tons)
  • Table 568. Cold Sore Treatment Sales Hospitals , by Region K Tons (2020-2025)
  • Table 569. Cold Sore Treatment Sales Homecare , by Region K Tons (2020-2025)
  • Table 570. Cold Sore Treatment Sales Specialty Clinics , by Region K Tons (2020-2025)
  • Table 571. Cold Sore Treatment Sales Others , by Region K Tons (2020-2025)
  • Table 572. Cold Sore Treatment Sales: by Drug Type(K Tons)
  • Table 573. Cold Sore Treatment Sales Antiviral Ointments , by Region K Tons (2020-2025)
  • Table 574. Cold Sore Treatment Sales Oral Antiviral Agents , by Region K Tons (2020-2025)
  • Table 575. Cold Sore Treatment Sales: by Route of Administration(K Tons)
  • Table 576. Cold Sore Treatment Sales Oral , by Region K Tons (2020-2025)
  • Table 577. Cold Sore Treatment Sales Topical , by Region K Tons (2020-2025)
  • Table 578. Cold Sore Treatment Sales: by Distribution Channel(K Tons)
  • Table 579. Cold Sore Treatment Sales Hospital Pharmacies , by Region K Tons (2020-2025)
  • Table 580. Cold Sore Treatment Sales Retail Pharmacies , by Region K Tons (2020-2025)
  • Table 581. Cold Sore Treatment Sales Online Pharmacies , by Region K Tons (2020-2025)
  • Table 582. Cold Sore Treatment Sales: by Virus Type(K Tons)
  • Table 583. Cold Sore Treatment Sales Herpes Simplex Type 1 Virus , by Region K Tons (2020-2025)
  • Table 584. Cold Sore Treatment Sales Herpes Simplex Type 2 Virus , by Region K Tons (2020-2025)
  • Table 585. South America Cold Sore Treatment Sales, by Country K Tons (2020-2025)
  • Table 586. South America Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 587. South America Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 588. South America Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 589. South America Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 590. South America Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 591. South America Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 592. Brazil Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 593. Brazil Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 594. Brazil Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 595. Brazil Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 596. Brazil Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 597. Brazil Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 598. Argentina Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 599. Argentina Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 600. Argentina Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 601. Argentina Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 602. Argentina Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 603. Argentina Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 604. Rest of South America Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 605. Rest of South America Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 606. Rest of South America Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 607. Rest of South America Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 608. Rest of South America Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 609. Rest of South America Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 610. Asia Pacific Cold Sore Treatment Sales, by Country K Tons (2020-2025)
  • Table 611. Asia Pacific Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 612. Asia Pacific Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 613. Asia Pacific Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 614. Asia Pacific Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 615. Asia Pacific Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 616. Asia Pacific Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 617. China Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 618. China Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 619. China Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 620. China Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 621. China Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 622. China Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 623. Japan Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 624. Japan Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 625. Japan Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 626. Japan Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 627. Japan Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 628. Japan Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 629. India Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 630. India Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 631. India Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 632. India Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 633. India Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 634. India Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 635. South Korea Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 636. South Korea Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 637. South Korea Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 638. South Korea Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 639. South Korea Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 640. South Korea Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 641. Taiwan Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 642. Taiwan Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 643. Taiwan Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 644. Taiwan Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 645. Taiwan Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 646. Taiwan Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 647. Australia Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 648. Australia Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 649. Australia Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 650. Australia Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 651. Australia Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 652. Australia Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 653. Rest of Asia-Pacific Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 654. Rest of Asia-Pacific Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 655. Rest of Asia-Pacific Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 656. Rest of Asia-Pacific Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 657. Rest of Asia-Pacific Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 658. Rest of Asia-Pacific Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 659. Europe Cold Sore Treatment Sales, by Country K Tons (2020-2025)
  • Table 660. Europe Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 661. Europe Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 662. Europe Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 663. Europe Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 664. Europe Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 665. Europe Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 666. Germany Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 667. Germany Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 668. Germany Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 669. Germany Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 670. Germany Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 671. Germany Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 672. France Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 673. France Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 674. France Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 675. France Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 676. France Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 677. France Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 678. Italy Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 679. Italy Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 680. Italy Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 681. Italy Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 682. Italy Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 683. Italy Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 684. United Kingdom Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 685. United Kingdom Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 686. United Kingdom Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 687. United Kingdom Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 688. United Kingdom Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 689. United Kingdom Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 690. Netherlands Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 691. Netherlands Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 692. Netherlands Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 693. Netherlands Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 694. Netherlands Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 695. Netherlands Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 696. Rest of Europe Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 697. Rest of Europe Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 698. Rest of Europe Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 699. Rest of Europe Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 700. Rest of Europe Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 701. Rest of Europe Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 702. MEA Cold Sore Treatment Sales, by Country K Tons (2020-2025)
  • Table 703. MEA Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 704. MEA Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 705. MEA Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 706. MEA Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 707. MEA Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 708. MEA Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 709. Middle East Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 710. Middle East Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 711. Middle East Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 712. Middle East Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 713. Middle East Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 714. Middle East Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 715. Africa Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 716. Africa Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 717. Africa Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
  • Table 718. Africa Cold Sore Treatment Sales, by Route of Administration K Tons (2020-2025)
  • Table 719. Africa Cold Sore Treatment Sales, by Distribution Channel K Tons (2020-2025)
  • Table 720. Africa Cold Sore Treatment Sales, by Virus Type K Tons (2020-2025)
  • Table 721. North America Cold Sore Treatment Sales, by Country K Tons (2020-2025)
  • Table 722. North America Cold Sore Treatment Sales, by Type K Tons (2020-2025)
  • Table 723. North America Cold Sore Treatment Sales, by Application K Tons (2020-2025)
  • Table 724. North America Cold Sore Treatment Sales, by Drug Type K Tons (2020-2025)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cold Sore Treatment: by Type USD Million (2014-2019)
  • Figure 5. Global Cold Sore Treatment: by Application USD Million (2014-2019)
  • Figure 6. Global Cold Sore Treatment: by Drug Type USD Million (2014-2019)
  • Figure 7. Global Cold Sore Treatment: by Route of Administration USD Million (2014-2019)
  • Figure 8. Global Cold Sore Treatment: by Distribution Channel USD Million (2014-2019)
  • Figure 9. Global Cold Sore Treatment: by Virus Type USD Million (2014-2019)
  • Figure 10. South America Cold Sore Treatment Share (%), by Country
  • Figure 11. Asia Pacific Cold Sore Treatment Share (%), by Country
  • Figure 12. Europe Cold Sore Treatment Share (%), by Country
  • Figure 13. MEA Cold Sore Treatment Share (%), by Country
  • Figure 14. North America Cold Sore Treatment Share (%), by Country
  • Figure 15. Global Cold Sore Treatment: by Type K Tons (2014-2019)
  • Figure 16. Global Cold Sore Treatment: by Application K Tons (2014-2019)
  • Figure 17. Global Cold Sore Treatment: by Drug Type K Tons (2014-2019)
  • Figure 18. Global Cold Sore Treatment: by Route of Administration K Tons (2014-2019)
  • Figure 19. Global Cold Sore Treatment: by Distribution Channel K Tons (2014-2019)
  • Figure 20. Global Cold Sore Treatment: by Virus Type K Tons (2014-2019)
  • Figure 21. South America Cold Sore Treatment Share (%), by Country
  • Figure 22. Asia Pacific Cold Sore Treatment Share (%), by Country
  • Figure 23. Europe Cold Sore Treatment Share (%), by Country
  • Figure 24. MEA Cold Sore Treatment Share (%), by Country
  • Figure 25. North America Cold Sore Treatment Share (%), by Country
  • Figure 26. Global Cold Sore Treatment: by Type USD/Units (2014-2019)
  • Figure 27. Global Cold Sore Treatment share by Players 2019 (%)
  • Figure 28. Global Cold Sore Treatment share by Players (Top 3) 2019(%)
  • Figure 29. Global Cold Sore Treatment share by Players (Top 5) 2019(%)
  • Figure 30. BCG Matrix for key Companies
  • Figure 31. Squarex (United States) Revenue, Net Income and Gross profit
  • Figure 32. Squarex (United States) Revenue: by Geography 2019
  • Figure 33. Merix Pharmaceutical Corp (United States) Revenue, Net Income and Gross profit
  • Figure 34. Merix Pharmaceutical Corp (United States) Revenue: by Geography 2019
  • Figure 35. AiCuris (Germany) Revenue, Net Income and Gross profit
  • Figure 36. AiCuris (Germany) Revenue: by Geography 2019
  • Figure 37. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2019
  • Figure 39. Medivir AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 40. Medivir AB (Sweden) Revenue: by Geography 2019
  • Figure 41. Renaissance Pharma, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Renaissance Pharma, Inc. (United States) Revenue: by Geography 2019
  • Figure 43. Deerfield (United States) Revenue, Net Income and Gross profit
  • Figure 44. Deerfield (United States) Revenue: by Geography 2019
  • Figure 45. Otsuka Holdings Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 46. Otsuka Holdings Co. Ltd. (Japan) Revenue: by Geography 2019
  • Figure 47. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Mylan N.V. (United States) Revenue: by Geography 2019
  • Figure 49. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 50. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2019
  • Figure 51. Cipla Inc. (India) Revenue, Net Income and Gross profit
  • Figure 52. Cipla Inc. (India) Revenue: by Geography 2019
  • Figure 53. Alembic Pharmaceuticals Limited (India) Revenue, Net Income and Gross profit
  • Figure 54. Alembic Pharmaceuticals Limited (India) Revenue: by Geography 2019
  • Figure 55. Zydus Cadila (India) Revenue, Net Income and Gross profit
  • Figure 56. Zydus Cadila (India) Revenue: by Geography 2019
  • Figure 57. Amneal Pharmaceuticals LLC (United States) Revenue, Net Income and Gross profit
  • Figure 58. Amneal Pharmaceuticals LLC (United States) Revenue: by Geography 2019
  • Figure 59. Sun Pharmaceutical Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 60. Sun Pharmaceutical Industries Ltd. (India) Revenue: by Geography 2019
  • Figure 61. Hetero Drugs (India) Revenue, Net Income and Gross profit
  • Figure 62. Hetero Drugs (India) Revenue: by Geography 2019
  • Figure 63. Global Cold Sore Treatment: by Type USD Million (2020-2025)
  • Figure 64. Global Cold Sore Treatment: by Application USD Million (2020-2025)
  • Figure 65. Global Cold Sore Treatment: by Drug Type USD Million (2020-2025)
  • Figure 66. Global Cold Sore Treatment: by Route of Administration USD Million (2020-2025)
  • Figure 67. Global Cold Sore Treatment: by Distribution Channel USD Million (2020-2025)
  • Figure 68. Global Cold Sore Treatment: by Virus Type USD Million (2020-2025)
  • Figure 69. South America Cold Sore Treatment Share (%), by Country
  • Figure 70. Asia Pacific Cold Sore Treatment Share (%), by Country
  • Figure 71. Europe Cold Sore Treatment Share (%), by Country
  • Figure 72. MEA Cold Sore Treatment Share (%), by Country
  • Figure 73. North America Cold Sore Treatment Share (%), by Country
  • Figure 74. Global Cold Sore Treatment: by Type K Tons (2020-2025)
  • Figure 75. Global Cold Sore Treatment: by Application K Tons (2020-2025)
  • Figure 76. Global Cold Sore Treatment: by Drug Type K Tons (2020-2025)
  • Figure 77. Global Cold Sore Treatment: by Route of Administration K Tons (2020-2025)
  • Figure 78. Global Cold Sore Treatment: by Distribution Channel K Tons (2020-2025)
  • Figure 79. Global Cold Sore Treatment: by Virus Type K Tons (2020-2025)
  • Figure 80. South America Cold Sore Treatment Share (%), by Country
  • Figure 81. Asia Pacific Cold Sore Treatment Share (%), by Country
  • Figure 82. Europe Cold Sore Treatment Share (%), by Country
  • Figure 83. MEA Cold Sore Treatment Share (%), by Country
  • Figure 84. North America Cold Sore Treatment Share (%), by Country
  • Figure 85. Global Cold Sore Treatment: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Squarex (United States)
  • Merix Pharmaceutical Corp (United States)
  • AiCuris (Germany)
  • GlaxoSmithKline plc (United Kingdom)
  • Medivir AB (Sweden)
  • Renaissance Pharma, Inc. (United States)
  • Deerfield (United States)
  • Otsuka Holdings Co. Ltd. (Japan)
  • Mylan N.V. (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Cipla Inc. (India)
  • Alembic Pharmaceuticals Limited (India)
  • Zydus Cadila (India)
  • Amneal Pharmaceuticals LLC (United States)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Hetero Drugs (India)
Additional players considered in the study are as follows:
Novartis AG (Switzerland) , Tolmar Pharmaceuticals, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation